- Home
- LTBR vs VIR Comparison
LTBR vs VIR Comparison
Compare LTBR & VIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LTBR
- VIR
- Stock Information
- Founded
- LTBR 1992
- VIR 2016
- Country
- LTBR United States
- VIR United States
- Employees
- LTBR N/A
- VIR N/A
- Industry
- LTBR Professional Services
- VIR Biotechnology: Pharmaceutical Preparations
- Sector
- LTBR Consumer Discretionary
- VIR Health Care
- Exchange
- LTBR Nasdaq
- VIR Nasdaq
- Market Cap
- LTBR 788.1M
- VIR 706.4M
- IPO Year
- LTBR N/A
- VIR 2019
- Fundamental
- Price
- LTBR $26.59
- VIR $6.24
- Analyst Decision
- LTBR
- VIR Strong Buy
- Analyst Count
- LTBR 0
- VIR 11
- Target Price
- LTBR N/A
- VIR $25.73
- AVG Volume (30 Days)
- LTBR 3.1M
- VIR 1.3M
- Earning Date
- LTBR 10-29-2025
- VIR 10-30-2025
- Dividend Yield
- LTBR N/A
- VIR N/A
- EPS Growth
- LTBR N/A
- VIR N/A
- EPS
- LTBR N/A
- VIR N/A
- Revenue
- LTBR N/A
- VIR $19,000,000.00
- Revenue This Year
- LTBR N/A
- VIR N/A
- Revenue Next Year
- LTBR N/A
- VIR $15.25
- P/E Ratio
- LTBR N/A
- VIR N/A
- Revenue Growth
- LTBR N/A
- VIR N/A
- 52 Week Low
- LTBR $4.35
- VIR $4.16
- 52 Week High
- LTBR $31.34
- VIR $14.45
- Technical
- Relative Strength Index (RSI)
- LTBR 63.34
- VIR 63.53
- Support Level
- LTBR $23.12
- VIR $5.71
- Resistance Level
- LTBR $31.34
- VIR $6.17
- Average True Range (ATR)
- LTBR 2.83
- VIR 0.35
- MACD
- LTBR 0.13
- VIR 0.01
- Stochastic Oscillator
- LTBR 59.11
- VIR 86.34
About LTBR Lightbridge Corporation
Lightbridge Corp is a United States-based nuclear fuel technology company. The business activity of the firm is functioned through one business segment, which is the development and commercialization of its nuclear fuel. The Nuclear Fuel Technology segment develops next generation nuclear fuel technology that increases the power output of commercial reactors and reduces the cost of generating electricity. Geographically, its operations are functioned through the region of Unites States.
About VIR Vir Biotechnology Inc.
Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.